Oncoclínicas do Brasil Serviços Médicos Management
Management criteria checks 1/4
Oncoclínicas do Brasil Serviços Médicos' CEO is Bruno Ferrari, appointed in Jan 2010, has a tenure of 15.33 years. directly owns 8.67% of the company’s shares, worth R$304.93M. The average tenure of the management team and the board of directors is 3.1 years and 1.3 years respectively.
Key information
Bruno Ferrari
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 15.3yrs |
| CEO ownership | 8.7% |
| Management average tenure | 3.1yrs |
| Board average tenure | 1.3yrs |
Recent management updates
Recent updates
Debt Reduction And Revenue Diversification Will Secure Future Stability
Apr 20 Strategic partnerships and revenue diversification efforts aim to stabilize and enhance growth, reducing reliance on major clients and expanding market reach.Earnings Tell The Story For Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) As Its Stock Soars 124%
Feb 22
Is Now An Opportune Moment To Examine Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)?
Feb 19Why We're Not Concerned Yet About Oncoclínicas do Brasil Serviços Médicos S.A.'s (BVMF:ONCO3) 30% Share Price Plunge
Jan 08Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) Has No Shortage Of Debt
Dec 30Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) Stocks Pounded By 29% But Not Lagging Market On Growth Or Pricing
Nov 23Oncoclínicas do Brasil Serviços Médicos' (BVMF:ONCO3) Problems Go Beyond Weak Profit
Nov 20Oncoclínicas do Brasil Serviços Médicos S.A. Reported A Surprise Loss, And Analysts Have Updated Their Forecasts
Nov 17With A 25% Price Drop For Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) You'll Still Get What You Pay For
Sep 27Here's What Analysts Are Forecasting For Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) After Its Second-Quarter Results
Aug 15Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) Takes On Some Risk With Its Use Of Debt
Aug 13Earnings Tell The Story For Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) As Its Stock Soars 27%
Jul 16Is Now An Opportune Moment To Examine Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)?
Jul 03Investors Appear Satisfied With Oncoclínicas do Brasil Serviços Médicos S.A.'s (BVMF:ONCO3) Prospects As Shares Rocket 25%
Jun 01Oncoclínicas do Brasil Serviços Médicos S.A.'s (BVMF:ONCO3) Share Price Is Still Matching Investor Opinion Despite 27% Slump
Apr 17Oncoclínicas do Brasil Serviços Médicos' (BVMF:ONCO3) Earnings Are Weaker Than They Seem
Apr 03Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) Has A Somewhat Strained Balance Sheet
Mar 11What Does Oncoclínicas do Brasil Serviços Médicos S.A.'s (BVMF:ONCO3) Share Price Indicate?
Feb 17It's A Story Of Risk Vs Reward With Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)
Dec 08Why Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) Could Be Worth Watching
Nov 06Is Now The Time To Put Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) On Your Watchlist?
Sep 11Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) Just Reported Earnings, And Analysts Cut Their Target Price
Apr 03CEO
Bruno Ferrari
15.3yrs
Tenure
Mr. Bruno Lemos Ferrari is CEO and Director of Oncoclínicas do Brasil Serviços Médicos S.A. from 2010 and serves as its Vice Chairman since May 2022. He serves as Chief Executive Officer and Director at Mu...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Vice Chairman & CEO | 15.3yrs | no data | 8.67% R$ 304.9m | |
| Chief Financial and Investor Relations Officer | 3.1yrs | no data | no data | |
| Director of M&A and Operations | less than a year | no data | no data | |
| Chief Technology Officer | 3.3yrs | no data | no data | |
| Director of Compliance & Legal | no data | no data | no data | |
| Human Resources Officer | no data | no data | no data | |
| Chief Strategy Officer & Board Member | less than a year | no data | no data |
3.1yrs
Average Tenure
Experienced Management: ONCO3's management team is considered experienced (3.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Vice Chairman & CEO | 15.3yrs | no data | 8.67% R$ 304.9m | |
| Chief Financial and Investor Relations Officer | less than a year | no data | no data | |
| Chief Strategy Officer & Board Member | no data | no data | no data | |
| Chairman | no data | no data | no data | |
| Director | 3yrs | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| President of the Fiscal Council | 2.3yrs | no data | no data | |
| Board Member | no data | no data | no data | |
| Board Member | no data | no data | no data | |
| Board Member | no data | no data | no data | |
| Independent Director | 1.3yrs | no data | no data | |
| Independent Director | less than a year | no data | no data |
1.3yrs
Average Tenure
54yo
Average Age
Experienced Board: ONCO3's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/07 03:02 |
| End of Day Share Price | 2025/05/07 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Oncoclínicas do Brasil Serviços Médicos S.A. is covered by 13 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Flavio Yoshida | BofA Global Research |
| Marcio Osako | Bradesco S.A. Corretora de Títulos e Valores Mobiliários |
| Carlos Palhares Sequeira | BTG Pactual |